APIs|Intermediates|Basic Chemicals|Formulation--Beijing Lunarsun Pharmaceutical Co., Ltd.
Generics development

Generics development

Beijing Lunarsun Pharmaceutical Co.,Ltd.

1. R&D team and facilities: We have an experienced team, including a team with over 15 years of domestic registration experience and a team with over 10 years of FDA raw material registration experience. They are very familiar with the domestic and international drug registration process and requirements, able to efficiently handle various registration affairs, and provide strong support for the international market development of the company's products.
2. Innovation capability: The company is committed to the research and development of generic drugs, and we are committed to innovative drug research and development, constantly exploring and applying new scientific technologies and research methods. Pay attention to technological innovation, actively apply for patents in the drug development process, and protect the intellectual property rights of research and development results. I have accumulated more than 10 years of experience in the research and application of generic drugs. The research and development of dosage forms includes oral solid preparations, oral liquid preparations, various sustained-release dosage forms, injections, nasal preparations, inhalation preparations, liniments, and other different types. For many years, we have established close cooperative relationships with well-known domestic and foreign research institutions and universities to share resources and carry out collaborative projects to accelerate the process of drug research and development.
3. Focusing on high quality: In order to ensure product quality and compliance, we have established a comprehensive and strict quality management system that complies with GMP and GSP standards. These systems include standard operating procedures, quality control processes, and risk assessments to ensure that our products always meet the highest quality standards during production, storage, and distribution.
4. Product research and development achievements: We have successfully developed a series of products that meet the real clinical needs, covering multiple disease fields. These products have undergone strict clinical trials and drug registration procedures, and have been approved and licensed by relevant regulatory agencies, providing patients with safe and effective treatment options.

Some of the developed products are shown in the table below

NO. Name Specifications Dosage form Indication
1 Granisetron Hydrochloride lnjection 3ml:3mg injection To prevent or treat nausea and vomiting caused by chemotherapy and radiotherapy; Prevention and treatment of postoperative nausea and vomiting.
2 ZhuSheYongTiJiaHuanSu 50mg injection (sterile powder for injection) Treatment of complex skin and skin structure infections; Complex abdominal infection; Community-acquired bacterial pneumonia.
3 Moxifloxacin hydrochloride Injection 250mL:Moxifloxacin 0.4g and hydrochlori 2.0g injection Prevention and plague; Treatment of sensitive bacterial infections; Acute onset of chronic bronchitis; Complex abdominal infection; Community-acquired pneumonia; The Plague; Skin and skin structure infection; Acute bacterial sinusitis.
4 Moxifloxacin hydrochloride Tablets 0.4g tablets Prevention and plague; Treatment of sensitive bacterial infections; Acute onset of chronic bronchitis; Complex abdominal infection; Community-acquired pneumonia; The Plague; Skin and skin structure infection; Acute bacterial sinusitis.
5 Oseltamivir Phosphate for Suspension 6mg/ml Oral suspension "1, for the treatment of influenza A and B in adults and children 1 week and above. 2, for the prevention of influenza A and B in patients aged 1 year and above."
6 Tadalafil Tablets 20mg tablets Treatment of erectile dysfunction (ED).
7 Mirabegron Sustained-release Tablets 50mg tablets(Sustained-release Tablets) Symptomatic management of urgency, frequency, and/or urge incontinence in adults with overactive bladder (OAB).
8 Atomoxetine Hydrochloride Oral Solution 0.4%(100ml:0.4g) Oral solution It is used to treat attention deficit/hyperactivity disorder (ADHD) in children and adolescents aged 6 years and older.
9 Famotidine Injection 1ml:10mg;2ml:20mg injection Upper digestive tract bleeding caused by peptic ulcer, gastric and duodenal mucosa erosion bleeding caused by various reasons other than tumor and esophageal and gastric fundus varicose veins.
10 Trazodone Hydrochloride Tablets 50mg tablets For depression with or without symptoms of anxiety.
11 Trazodone Hydrochloride Sustained-release Tablets 75mg tablets(Sustained-release Tablets) For depression with or without symptoms of anxiety.

More products are welcome for consultationChongqing Shisen Pharmaceutical Technology Co., Ltd.